chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient called pharmacy on 7/30/21 reporting they received the Pfizer Covid vaccine on Thursday 7/29/21 and then woke up on Friday 7/30/21 with fever, body ache, and headache. They were asking what they could take for these symptoms. I recommended Tylenol, however the patient said they did not have any Tylenol at home and only had Nyquil with acetaminophen as one of three ingredients. The patient said they would just take the Nyquil so they wouldn't have to go to the store to get any medication.
headache; some dizziness; chills; joint and muscle pain; joint and muscle pain; feeling unwell; tiredness; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer(patient) reported that:  A 71-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot Number: EN6198) via an unspecified route of administration in left arm on 26Feb2021 10:00 (at the age of 71-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history were none. The patient had no known allergies. The patient's concomitant medications were not reported. The patient did not receive other vaccine within four weeks prior vaccination. Other medications in two weeks were dietary supplements. The patient had no COVID prior vaccination, no COVID tested post vaccination. On 27Feb2021, the patient experienced tiredness, headache, some dizziness, chills, joint and muscle pain and generally feeling unwell. No treatment was given for the events. The outcome of the events was not recovered at the time of last observation. It was reported that, the patient stated that she got her first shot on 10Mar2021, and she was supposed to get the second dose on 26Mar2021. Her doctor changed the schedule to 31Mar2021 because 26Mar 2021 was less than 21 days. However, she received a phone call yesterday that the schedule for her second dose has changed on 01Apr2021 (more than 21 days). The unaddressed medical questions was referred to Medical Information.  No follow-up attempts are possible. No further information is expected.
Approximately around 2-3 minutes after patient's vaccination she experienced the following symptoms - Sore arm, Tingling in the finger (right side), shortness of breath, Fatigue that last about  11 days, neck pain, headache and stomach ache - all these symptoms lasted about 10 - 11 days. She has lost her appetite for about 4 days. The symptoms went away after the 12th day and came back right away after 2 days (All symptoms mentioned).  For treatment I gave her Motrin (4x per 24 hours) and gave her nebulize treatment but nothing worked. We had a televisit with the doctor and  was advised that if the headache was happening too long we should go to the ER.  As of today some of the symptoms subsided except for the headache and some slight stomach ache.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The nurse reported that an unspecified number of patients received ROTATEQ (lot number, dose, frequency, route not specified) that were exposed to 51F (Fahrenheit) for 228 hours, which was an excursion that was found to be unsupported by in-house stability data. No adverse symptoms reported. No further information provided. All telephone attempts to obtain follow-up information have been unsuccessful. Follow up was received from an immunization coordinator on 17-APR-2014. ROTATEQ was exposed to temperatures of 32F for 110 hours then 51F for 228 hours (temperature excursion not supported by stability data). No adverse effects reported. This is one of several reports from the same source (1402USA007570, 1404USA012060, 1404USA012061 and 1404USA012062). Additional information has been requested.
Immediately, felt burning at injection site, then mild headache, lips tingling. . About 40 minutes later, lips and tongue swelling, and uncomfortable swallowing.
Information has been received from a RN and a physician concerning an 81 year old female who was vaccinated on 04-DEC-2001 with a second dose of pneumococcal vaccine 23 polyvalent. The pt was vaccinated with the first dose of an unspecified pneumococcal vaccine about 15 years ago without incident. The second dose was given on 04-DEC-2001 at 13:20 in the office. About 12 hours later, the pt had to be seen by paramedics, but not taken to the ER due to a rash across the abdomen, bradycardia, severe itching of the hands and face, SOB and passing out. The pt was treated per "anaphylactic reaction protocol" including epinephrine and Medrol. On 05-DEC-2001 per a phone interview between the pt and the physician, the pt was fatigued but stable and "clearly turning around" with the itching resolving. Upon internal reviwe, the pt's anaphylactic reaction was considered an other medical event. Additional information has been requested. Additional information was received from the registered nurse. The patient was vaccinated with an influenza vaccine (manufacturer unknown) approximately 10 days prior to vaccination with pneumococcal vaccine 23 polyvalent. It was reported that the patient received pneumococcal vaccine 23 polyvalent in the left arm. The patient subsequently recovered from the anaphylactic reaction. Upon internal review, the patient's anaphylactic reaction was considered an other medical event. No additional information is expected.
Major knee swelling, could not walk on leg, fatigue, feet turned purple, rashes on legs.
pain and swollen lymph nodes in armpit for 3 days/nights.  Normal now.
3 inch in diameter, raised, red, hot injection site , sharp shooting headache,  fever.   Have stayed on ibuprofen /acetaminophen and iced the injection spot but the redness and heat has not subsided.
This spontaneous report as received from a consumer refers to her son who was a 13 years old male patient with no pertinent medical history and no drug reactions/allergies. The patient was vaccinated with PNEUMOVAX 23 (Lot# reported as U4262AC, dose and route unspecified) on 18-JUL-2012. There was no concomitant therapy. On 07-SEP-2012 the patient was then hospitalized and later diagnosed with meningitis. The patient had sought medical attention and antibiotics was given for the event. At the time of reporting the outcome of meningitis was unknown. Additional information has been requested.
77-year-old female with past medical history of rheumatoid arthritis, scoliosis, who presented to the emergency room for evaluation of loss of appetite, cough, generalized weakness for few weeks, since getting her covid 19 booster. Patient's family states that patient has been nauseous on and off for weeks and has been constipated, and patient was supposed to see her PMD today but she came to the emergency room instead for further evaluation.   In the ED, Troponin negative, influenza a and B negative, COVID-19 is positive. Lactic acid 1.03. WBC 2.6. Chest x-ray shows interstitial infiltrates versus interstitial edema.
arm hurt for about 4 days; weak; sickly; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), ILLNESS (sickly) and VACCINATION SITE PAIN (arm hurt for about 4 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced ASTHENIA (weak) and ILLNESS (sickly). On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm hurt for about 4 days). In March 2021, VACCINATION SITE PAIN (arm hurt for about 4 days) had resolved. At the time of the report, ASTHENIA (weak) and ILLNESS (sickly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported   This case was linked to MOD-2021-427703 (Patient Link).
Information has been received from a physician concerning a 68 year old female who on unspecified date was vaccinated into shoulder of the arm (unspecified which arm) with PNEUMOVAX (lot # and dose # were unspecified). It was reported that on unspecified date the patient developed injection site reaction of redness, swelling and low grade fever. Unspecified medical attention was sought by visiting office. At the time of this report the patient had not recovered. No other information available. Additional information is not expected.
Is itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Is itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PRURITUS (Is itchy). At the time of the report, PRURITUS (Is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment medications were not reported.   Reporter did not allow further contact
moderate myalgia; This is a spontaneous report from a non-contactable consumer.  A 30-year-old female patient (daughter of a friend) received bnt162b2 ((Pfizer-BioNTech COVID-19 mRNA vaccine) lot number and expiration date were not reported, via an unspecified route of administration on 17Dec2020 at a single dose for COVID vaccination. The patient's medical history and concomitant medications were not reported. The patient experienced moderate myalgia following her COVID vaccination last Thursday on 17Dec2020 with outcome of recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Modern a COVID-19 Vaccine  About 11 days after taking the vaccine my arm started to itch. On the 13th day my arm is very red.
Red, Swollen Arm. Muscle aches, flu like symptoms, joint pain. Has a scar on her arm that is typically flat, but is raised as a result of inflammation
Headache, Myalgia, Fever, pain to inj site, chills, fever, headache, myalgia, tiredness Narrative:  Day 1 - pain to inj site; chills, fever, headache, myalgia, tiredness; Day 2 - chills, fever, headache, myalgia, tiredness
fever; pain/soreness getting progressively worse for 4 days; the felt internal hives; burning sensation and felt like every nerve in my body was on fire for 3 days; soreness getting progressively worse for 4 days; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 09:00 (Lot number: EW0173) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies:Penicillin" (unspecified if ongoing); "history of Atrial fib" (unspecified if ongoing), notes: history of Atrial fib; "seizure disorder" (unspecified if ongoing), notes: seizure disorder -- 32 years seizure free. There were no concomitant medications. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine", notes: Known allergies: Codeine; Biaxin, reaction(s): "Known allergies: Biaxin", notes: Known allergies: Biaxin. The following information was reported: PYREXIA (non-serious) with onset 01May2021 09:00, outcome "recovered" (May2021), described as "fever"; PAIN (non-serious) with onset 01May2021 09:00, outcome "recovered" (May2021), described as "pain/soreness getting progressively worse for 4 days"; URTICARIA (non-serious) with onset 01May2021 09:00, outcome "recovered" (May2021), described as "the felt internal hives"; BURNING SENSATION (non-serious) with onset 01May2021 09:00, outcome "recovered" (May2021), described as "burning sensation and felt like every nerve in my body was on fire for 3 days"; CONDITION AGGRAVATED (non-serious) with onset 01May2021 09:00, outcome "recovered" (May2021), described as "soreness getting progressively worse for 4 days". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, pain, urticaria, burning sensation, condition aggravated. Additional information: The patient did not receive any other vaccine within 4 weeks prior to covid vaccine. The patient did not receive any other medication within 2 weeks prior to covid vaccine. Prior to vaccination the patient was not diagnosed with covid-19. Since vaccination the patient has not been tested for Covid-19. No follow-up attempts are possible. No further information is expected.
Patient had minimal reaction to the first Moderna vaccination--nothing more than a sore arm. Ten days later he awoke feeling dehydrated and drank some water which he immediately vomited back up. No food had been consumed. He then developed a cutting sore throat (as in the feeling of strep throat) and developed a fever of 101+ along with general joint aches. In about four hours the fever dropped abruptly along with the sore throat. Patient felt tired the rest of the day then awoke the next day feeling fine.
Patient given Hepatitis B IM upper (L) deltoid on 4/7/17. She stated at time of administration vaccine hurt slightly more than all other vaccines given. TYPHIM VI (L) lower deltoid, FLUCELVAX (R) deltoid IM, PNEUMOVAX 23 SQ (R) arm. After 3 day (R) arm stopped hurting, (L) upper arm still continues to be slightly painful like with abduction of arm and external rotation, presented on 5/5/17. No numbness.
Red chickenpox blisters at injection site (oldest blisters which iis now crusting) that started 15 days after injection, back of neck(older blister hasn't crusted yet), above left buttocks(older blister that hasn't crusted yet), and around mouth(smaller and just starting).
Patient developed abdominal distension & increased frequency of apneic & bradycardic events requiring vigorous stimulation. Abdominal xrays were obtained & arterial puncture performed to obtain blood for sepsis screen (CBC with diff, CRP, Blood culture) empirically & bladder catheterization performed for urine culture. Patient treated with VANCOMYCIN & CEFEPIME.   9/25/09 Received hospital medical records & transfer summary of 9/13/09. FINAL DX: complications of extreme prematurity, persistent pulmonary HTN, chronic lung disease, ROP stage III, liver failure, cholestasis, thrombocytopenia, IVH, rickets, femur fracture, growth failure, nephrocalcinosis, inguinal hernia bilateral Records reveal patient experienced complicated maternal pregnancy & delivery.  ICU for lengthy complicated stay.  O 8/11 day of vaccination, developed respiratory distress, decreased bowel sounds, lethargy.  Sepsis w/u neg.  Back to baseline by 8/13.
This spontaneous report as received from a physician refers to multiple unspecified patients of unknown age and gender No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported.  On an unknown date, the patients were vaccinated with M-M-R II (dosing details, lot#, expiry date were not reported) for prophylaxis. On an unknown date, the patients had negative titers for one or more of the components of M-M-R II. The outcome of events was unknown. The reporter did not provide the causality between the events and M-M-R II. There were no product quality complaints (PQC) involved. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of swelling in a adult patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced swelling and pain. On an unknown date, the outcome of the swelling and pain were unchanged. It was unknown if the reporter considered the swelling and pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. On an unknown date, at 11, the patient received a dose of SHINGRIX. The reporter provided very limited information due to time constraint. No further information was provided.
Starting the next day(s) after receiving the first dose vaccination I have had Tinnitus. The ringing is in my right ear and varies in intensity from day to day. The ringing has had little change in intensity overall. This symptom has persisted over the last 3 months.  There is no treatment for Tinnitus.
Severe headaches, nausea, fatigue, lost a taste, dizziness, chest pains, underarm/left lymph nodes swelled, fever, hard to breathe, oxygen levels low 86
puffy; Itchy; red; sore arm; tender arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tender arm), SKIN SWELLING (puffy), PRURITUS (Itchy), ERYTHEMA (red) and PAIN (sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ATORVASTATIN for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced TENDERNESS (tender arm) and PAIN (sore arm). On 29-Jan-2021, the patient experienced SKIN SWELLING (puffy), PRURITUS (Itchy) and ERYTHEMA (red). On 29-Jan-2021, TENDERNESS (tender arm) and PAIN (sore arm) had resolved. At the time of the report, SKIN SWELLING (puffy), PRURITUS (Itchy) and ERYTHEMA (red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
INFLAMMATION TO THE HAND  SEVERE HEADACHES  FLU SYMPTOMS  PALPATATIONS  WITH HEART RATE IN 160 AT TIMES -- FOLLOWING WITH CARDIOLOGY
35 y/o with asthma (on alvesco and singulair), GERD, morbid obesity (BMI 45)  and RA (on prednisone and MTX, SZA.) Vaccinated for COVID 2.12. and 3.10 Recent lab 3/17- normal, including negative CRP. Code continued for 50 minutes, no shock advised.  PEA, gave Epi X 4.  Normal BS. Considered narcan. Over the weekend- 4/17 Chest pain that started with eating. Labile blood pressure.  EKG showed NSR rate 64.  Treated with ASA 325, clear liquid diet and rest.  Treated with toradol and Zofran. Improved.  At f/u on Monday, discussed chronic knee pain was overall better.  Normal for her exam.  BP 136/79.  Felt dizzy and then passed out, hitting her head, became pulseless an apneic and was coded for over an hour.
I have a headache, severe pain in my left arm, nausea (starting about 1:30 pm), extreme tiredness and fatigue (starting at 12:30 pm) that has continued the whole day.
Facial swelling, lip swelling, altered sensation on tongue and scratchy throat. visible hives on face
Initial and follow-up information has been received from a physician concerning a patient who was inadvertently vaccinated with a dose of Pneumovax 23 instead of a fourth dose Prevnar. The physician stated that there was an error on the part of the office. Specifically, 70 doses of Pneumovax 23 were ordered instead of Prevnar because both products were next to each other on the order form. It was reported that 40 doses were administered with the belief that they were Prevnar. It was reported that there was no confusion in regards to product packaging. The physician stated that the problem had been corrected at the office and did not foresee any future problems. On an unspecified date, the patient returned to the physician's office and was vaccinated with a fourth dose of Prevnar. There were no adverse experiences reported. Follow-up reported that the patient had "done well" and no pneumococcal infection had been noted. Additional information is not expected.
Limb discomfort; Vaccination site pain; Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Limb discomfort), VACCINATION SITE PAIN (Vaccination site pain) and MYALGIA (Myalgia) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Nickel sensitivity and Drug allergy. Concomitant products included IBUPROFEN for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced LIMB DISCOMFORT (Limb discomfort), VACCINATION SITE PAIN (Vaccination site pain) and MYALGIA (Myalgia). At the time of the report, LIMB DISCOMFORT (Limb discomfort), VACCINATION SITE PAIN (Vaccination site pain) and MYALGIA (Myalgia) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
11 x 16 cm erythematous blanchable rash noted on left thigh. Central head noted, no fluctuance/induration noted. No abscess or cellulitis, no pain to the touch; Warm to touch. Pt has had several dose of BENADRYL, placed ice on area, MOTRIN for discomfort.
p/receiving vax pt stated felt dizzy & nauseated; then pt fainted & started shaking & having jerking motions all over for approx 5 to 7 seconds;
Started with itching burning rashes neuropathy headaches fatigue and dizziness. Now have mouth sores that won?t heal and debilitating malaise fatigue  A few days later:  Joint pain and air hunger   A few days later:  Numb extremities   Two weeks to date:  Body temp regulation issues , heart pounding, face flush.  Sleep disturbance entire time. Extreme fatigue.
Sister called and said patient's lips swollen, tingling in hands and pain in left arm. Advised to go to ER or page family MD.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 12 months old infant patient and unknown gender. On 11-SEP-2014 the patient was vaccinated with PROQUAD (Merck) (lot # K006771, expiration date 07-NOV-2015)(dose, route not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. The reporter also stated that as of 29-AUG-2014 they had 18 doses left of this lot number. This is one of several reports received from the same source. Additional information has been requested.
Awoke morning after vaccinations (one in each deltoid) with symmetrically swollen, red hands.  Difficult to move fingers because of swelling, but no joint pain.  No skin changes other than diffuse redness.  No itchiness.  A few body aches, but no other systemic symptoms.  No respiratory distress.  Improved over course of day.
Information has been received from a physician concerning a 73 year old female with osteoporosis and renal insufficiency and a history of hypothyroidism and high blood pressure who the year 2000 was vaccinated with a dose of PNEUMOVAX 23. The patient did not experienced any symptoms after being vaccinated with the first dose of PNEUMOVAX 23. On 27-OCT-2007 the patient was vaccinated intramuscularly in the left arm with a "standard dose " of PNEUMOVAX 23 (lot # 655233/0200U). Concomitant therapy included DIOVAN, FELODIPIN, ACTONEL, vitamin D unspecified, calcium (unspecified) and levothyroxine Na. On 27-OCT-2007 the patient developed an allergic reaction after vaccination. Symptoms began about one hours after vaccination. The patient developed symptoms of pain and swelling at the injection site on the left arm. The site was also "itchy". The worst of the symptoms was dated on Saturday 27-OCT-2007. The patient took aspirin (unspecified brand) for the pain. Follow up information obtained indicated that the now 74 year old patient weighing 123 pounds and with no known allergies, was vaccinated in the left arm with a dose of PNEUMOVAX 23 (lot# 656233/0200U). On 27-OCT-2007 the patient developed erythema, edema, and pain in the left arm. Subsequently the patient recovered. No further information is available.